Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Biocon Gains 4%; BSE HEALTHCARE Index Down 0.1%
Wed, 26 Jun 15:22

Biocon Gains 4%; BSE HEALTHCARE Index Down 0.1%Image source: peterschreiber.media/www.istockphoto.com

Biocon share price has zoomed 4% and is presently trading at Rs 351.5.

Meanwhile, the BSE HEALTHCARE index is at 36,720.0 (down 0.1%).

Among the top gainers in the BSE HEALTHCARE index today are SUN PHARMA ADV. RES. (up 3.7%) and GRANULES INDIA (up 3.1%).

APOLLO HOSPITALS (down 2.5%) and HIKAL CHEMIC (down 2.2%) are among the top losers today.

Over the last one year, Biocon has moved up from Rs 240.0 to Rs 351.5, registering a gain of Rs 111.6 (up 46.5%).

On the other hand, the BSE HEALTHCARE index has moved up from 25,266.1 to 36,720.0, registering a gain of 45.3% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Cadila Healthcare (up 90.3%), Glenmark Pharma (up 90.0%) and GSK Pharma (up 82.4%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 78,704.3 (up 0.8%).

The top gainers among the BSE Sensex today are Reliance Ind. (up 4.4%) and Bharti Airtel (up 3.2%). The most traded stocks in the BSE Sensex are Tata Steel and Reliance Ind..

In the meantime, NSE Nifty is at 23,877.2 (up 0.7%). Reliance Ind. and Bharti Airtel are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 62,970.0 to 78,704.3, registering a gain of 15,734.3 points (up 25.0%).

Biocon Financial Update...

Biocon net profit fell 50.4% YoY to Rs 2,256 million for the quarter ended March 2024, compared to a profit of Rs 4,546 million a year ago. Net sales rose 3.8% to Rs 39,171 million during the period as against Rs 37,739 million in January-March 2023.

For the year ended March 2023, Biocon reported 16.7% decrease in net profit to Rs 6,430 million compared to net profit of Rs 7,716 million during FY22. Revenue of the company grew 36.5% to Rs 111,742 million during FY23.

The current Price to earnings ratio of Biocon, based on rolling 12 month earnings, stands at 30.5.


Equitymaster requests your view! Post a comment on "Biocon Gains 4%; BSE HEALTHCARE Index Down 0.1%". Click here!